170 related articles for article (PubMed ID: 7542773)
1. Activation of trypsinogen in experimental models of acute pancreatitis in rats.
Nakae Y; Naruse S; Kitagawa M; Hirao S; Yamamoto R; Hayakawa T
Pancreas; 1995 Apr; 10(3):306-13. PubMed ID: 7542773
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats.
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
Pancreas; 1998 Oct; 17(3):289-94. PubMed ID: 9788544
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
4. Do plasma and urine trypsinogen activation peptides (TAP) really increase in trypsin-taurocholate-induced pancreatitis?
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
Pancreas; 2000 May; 20(4):389-93. PubMed ID: 10824694
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone affects inflammation but not trypsinogen activation in experimental acute pancreatitis.
Muller CA; Belyaev O; Appelros S; Buchler M; Uhl W; Borgstrom A
Eur Surg Res; 2008; 40(4):317-24. PubMed ID: 18303267
[TBL] [Abstract][Full Text] [Related]
6. Sequential changes in pancreatic markers in acute pancreatitis.
Lempinen M; Stenman UH; Puolakkainen P; Hietaranta A; Haapiainen R; Kemppainen E
Scand J Gastroenterol; 2003 Jun; 38(6):666-75. PubMed ID: 12825877
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.
Wartmann T; Mayerle J; Kähne T; Sahin-Tóth M; Ruthenbürger M; Matthias R; Kruse A; Reinheckel T; Peters C; Weiss FU; Sendler M; Lippert H; Schulz HU; Aghdassi A; Dummer A; Teller S; Halangk W; Lerch MM
Gastroenterology; 2010 Feb; 138(2):726-37. PubMed ID: 19900452
[TBL] [Abstract][Full Text] [Related]
8. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats.
Hofbauer B; Saluja AK; Lerch MM; Bhagat L; Bhatia M; Lee HS; Frossard JL; Adler G; Steer ML
Am J Physiol; 1998 Aug; 275(2):G352-62. PubMed ID: 9688663
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cathepsin B does not affect the intracellular activation of trypsinogen by cerulein hyperstimulation in isolated rat pancreatic acinar cells.
Klonowski-Stumpe H; Lüthen R; Han B; Sata N; Häussinger D; Niederau C
Pancreas; 1998 Jan; 16(1):96-101. PubMed ID: 9436869
[TBL] [Abstract][Full Text] [Related]
10. Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats.
Hartwig W; Jimenez RE; Werner J; Lewandrowski KB; Warshaw AL; Fernández-del Castillo C
Gastroenterology; 1999 Sep; 117(3):717-25. PubMed ID: 10464149
[TBL] [Abstract][Full Text] [Related]
11. Premature trypsinogen activation during cerulein pancreatitis in rats occurs inside pancreatic acinar cells.
Lüthen R; Owen RL; Sarbia M; Grendell JH; Niederau C
Pancreas; 1998 Jul; 17(1):38-43. PubMed ID: 9667518
[TBL] [Abstract][Full Text] [Related]
12. Correlation of trypsin-plasma inhibitor complexes with mortality in experimental pancreatitis in rats.
Largman C; Reidelberger RD; Tsukamoto H
Dig Dis Sci; 1986 Sep; 31(9):961-9. PubMed ID: 3488185
[TBL] [Abstract][Full Text] [Related]
13. Effect of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis.
Foitzik T; Hotz HG; Schmidt J; Klar E; Warshaw AL; Buhr HJ
Dig Dis Sci; 1995 Oct; 40(10):2184-8. PubMed ID: 7587786
[TBL] [Abstract][Full Text] [Related]
14. Evidence for extraluminal trypsinogen activation in three different models of acute pancreatitis.
Foitzik T; Lewandrowski KB; Fernández-del Castillo C; Rattner DW; Warshaw AL
Surgery; 1994 Jun; 115(6):698-702. PubMed ID: 8197561
[TBL] [Abstract][Full Text] [Related]
15. The effect of a cholecystokinin receptor antagonist lorglumid on the proteinase-antiproteinase balance in taurocholate acute experimental pancreatitis (AEP) in rats.
Kosidło S; Rydzewska G; Gabryelewicz A
Mater Med Pol; 1992; 24(4):223-6. PubMed ID: 1308047
[TBL] [Abstract][Full Text] [Related]
16. Monitoring serum tryptic activity and effect of trypsin inhibitor on rat acute pancreatitis.
Sobajima H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Ishiguro H; Tanikawa M; Nakae Y
Digestion; 1994; 55(2):90-6. PubMed ID: 7514553
[TBL] [Abstract][Full Text] [Related]
17. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats.
Gabryelewicz A; Kosidlo S; Prokopowicz J; Podkowicz K
Hepatogastroenterology; 1986 Apr; 33(2):79-82. PubMed ID: 2424815
[TBL] [Abstract][Full Text] [Related]
18. The pH modulator chloroquine blocks trypsinogen activation peptide generation in cerulein-induced pancreatitis.
Seyama Y; Otani T; Matsukura A; Makuuchi M
Pancreas; 2003 Jan; 26(1):15-7. PubMed ID: 12499911
[TBL] [Abstract][Full Text] [Related]
19. Trypsin and activation of circulating trypsinogen contribute to pancreatitis-associated lung injury.
Hartwig W; Werner J; Jimenez RE; Z'graggen K; Weimann J; Lewandrowski KB; Warshaw AL; Fernández-del Castillo C
Am J Physiol; 1999 Nov; 277(5):G1008-16. PubMed ID: 10564107
[TBL] [Abstract][Full Text] [Related]
20. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
